Multidrug resistance in pathogenic microorganisms is increasing at an alarming rate, threatening human health around the world. Despite the World Health Organization's declaration over 10 years ago that tuberculosis was a global health emergency, the tuberculosis problem has worsened (1).
Therefore, new antimycobacterial agents are needed to treat Mtb strains resistant to existing drugs and to shorten the treatment course to improve patient compliance (2, 3) .
Nucleoside metabolic pathways are a good source of new targets for anti-bacterials, as the enzymes/pathways involved are often different from their human counterparts. One of the promising pathways for the development of novel nucleoside analogs with antitubercular activity is the purine salvage pathway. Mycobacteria preferentially use adenosine kinase (ADK) 3 to directly phosphorylate Ado, even though they have purine nucleoside phosphorylase (Rv3307) and adenosine deaminase (Rv3313c) (4, 5) . Therefore, ADK may represent a good bioactivator/prodrug target because of its inherent capability to phosphorylate therapeutically useful purine nucleoside analogs and convert them into active nucleosides (6) .
ADK belongs to the phosphofructokinase B (PfkB) family of carbohydrate kinases, which includes ribokinase (RK), inosineguanosine kinase, fructokinase, and 1-phosphofructokinase (7) (8) (9) . However, Mtb ADK has a very low sequence similarity (less than 20%) with eukaryotic ADKs. Based on the amino acid sequence, Mtb ADK is closely related to RK from Escherichia coli (25% identity) (10) . In E. coli, RK catalyzes the phosphorylation of ribose to ribose 5-phosphate, part of the pentose phosphate pathway. Both Mtb ADK and E. coli RK are dimers, whereas all other known ADKs, including human ADK, are monomers (11) (12) (13) . Mtb ADK is encoded by the gene Rv2202c. It has recently been identified and cloned, and its gene product has been characterized biochemically (14) .
Mtb ADK phosphorylates adenosine (K m ϭ 0.8 M) to adenosine monophosphate using ATP (14) . Studies have shown that Ado analogs, like 2-methyladenosine, act as proinhibitors in Mtb, i.e. they require activation via phosphorylation before inhibiting other enzymes involved in DNA synthesis (15) . The minimum inhibitory concentration of 2-methyladenosine on the cell growth of Mtb was determined to be 3.1 g/ml (11 M) (16) . Indeed, the antitubercular activity of 2-methyladenosine is directly dependent on ADK activity (15, 16) . It has been shown that ADK activity in 2-methyladoenosine-and 2-fluoroad-enosine-resistant Mycobacterium smegmatis strains (SRI101 and SRI301) was significantly lower (Ͻ10 nmol/mg/min for SRI101 and Ͻ110 nmol/mg/min for SRI301) as compared with wild-type M. smegmatis mc 2 155 (3400 nmol/mg/min), suggesting that ADK is responsible for the activation of these nucleoside analogs to toxic metabolites (17) . 2-Methyladenosine has also been shown to inhibit the growth of Mtb in infected macrophages in a hypoxic shift-down model (18) . This suggests that nucleoside analogs phosphorylated by ADK may show inhibitory efficiency against Mtb in the persistent state (16) .
2-Methyladenosine was shown to possess fairly selective activity against Mtb, signifying the differences in the substrate preferences between mycobacterial and human purine metabolic enzymes. Human ADK shows a K m of 960 M for 2-methyladenosine, whereas Mtb ADK shows a K m of 79 M (14). Besides 2-methyladenosine, several other nucleoside analogs with modifications to the adenine ring have been analyzed and found to possess promising antitubercular activity (19) . For example, the fluorinated analogs, such as 2-fluoro-3-deazaadenosine, 3-fluoro-3-deaza-adenosine, and 2,3-difluoro-3-deaza-adenosine, not only exhibited antitubercular activity but also proved to be better substrates for Mtb ADK than human ADK (20 -23) . The substrate-specific activities of 2-fluoro-3-deaza-adenosine, 3-fluoro-3-deaza-adenosine, and 2,3-difluoro-3-deaza-adenosine for Mtb ADK were 63, 16, and 81 nmol/mg/min, respectively; whereas for human ADK they were Ͻ0.5, 1, and 6 nmol/mg/min (23) , indicating that differences exist between the substrate binding sites of these enzymes.
To provide further insight into the structure, function, and inhibition of Mtb ADK, we have solved the crystal structure of Mtb ADK to 1.5-Å resolution using multiwavelength anomalous dispersion (MAD). We also report the structural basis for the binding of adenosine, ATP analog (AMP-PCP), and 2-fluoroadenosine to ADK through three binary complex structures.
EXPERIMENTAL PROCEDURES
The substrates and their analogs (adenosine, 2-fluoroadenosine, and AMP-PCP) were obtained from Sigma. A Hi-Trap nickel chelating column from GE Healthcare was used for protein purification. Crystal screen solutions from Hampton Research and Emerald Biosciences were used for obtaining ADK crystals.
Cloning, Protein Expression, and Purification-A 972-bp DNA fragment containing the ADK (Rv2202c accession no. Q10391) gene was amplified by PCR with Mtb H37Rv genomic DNA as a template. The following oligonucleotides were used: 5Ј-AGATGAAGCATATGACGATCGCGGTA-ACCGGTTC-3Ј and 5Ј-AGATGACTCGAGTTAGGCCA-GCACGGCGACGATCTC-3Ј. The amplified DNA fragment was digested with NdeI and XhoI restriction enzymes and subcloned into the corresponding restriction sites in the pET28b vector containing an N-terminal His tag (Novagen). The DNA was subcloned using NdeI and EcoRI restriction sites into the pET28b vector (Novagen) to generate a recombinant vector containing a 5Ј sequence encoding a 20-amino acid N-terminal His tag and a tobacco etch virus cleavage site. After ligation, the plasmid was transformed into E. coli BL21(DE3) for expression of apo-protein and E. coli B834(DE3) cells for producing selenomethionine-incorporated protein. For protein expression, cell cultures were grown in LB media at 37°C. The cells were induced with 0.75 mM isopropyl 1-thio-␤-D-galactopyranoside when the cell density reached A 600 ϳ 0.6 -1.0. Cell cultures were incubated for about 18 h at 20°C before harvest. Selenomethionylated (SeMet) protein was prepared according to published methods (24) .
The harvested cells were lysed using a French press, and the cell suspension was centrifuged at 15,000 ϫ g for 1 h. Recombinant ADK protein was purified by a nickel affinity column, making use of the engineered His 6 tag at the N terminus. For purification buffers, 20 mM Tris-HCl, pH 7.5, containing 500 mM NaCl, 10-500 mM imidazole, and 5% glycerol were used. The His tag was then cleaved by dialyzing the protein (in the presence of 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 5% glycerol, and 1 mM dithiothreitol) with tobacco etch virus protease. The tobacco etch virus and tag were then separated from ADK by passing the dialyzed sample through another nickel affinity chromatography column. Purified ADK was dialyzed a second time in the same composition buffer as before. Purified recombinant protein was concentrated to 20 mg/ml prior to crystallization. The protein was more than 95% pure as observed by SDS-PAGE.
Crystallization-Crystals were obtained by either hanging drop or sitting drop vapor diffusion methods. A protein concentration of 15-20 mg/ml was mixed with an equal volume (2 l) of precipitant solution and incubated at 19°C, forming a 4 -5-l drop. Apo-SeMet ADK was found to crystallize in 1.0 M potassium/sodium tartrate and 0.1 M MES, pH 6.0, by screening with Crystal Screen I and II (Hampton) and Wizard I and II (Emerald Biosciences). The crystals of the apo-ADK and ADK⅐AMP-PCP complex were obtained by mixing equal volumes (2 l) of 18 mg/ml protein (preincubated for 2 h at room temperature with 5 mM AMP-PCP) with 20% PEG 8000, 100 mM sodium cacodylate, pH 6.5, and 200 mM magnesium acetate tetrahydrate. For the substrate-bound protein crystals, ADK was preincubated with 5 mM adenosine/2-fluoroadenosine for 1 h at room temperature prior to setting up crystal plates. Crystals were obtained in conditions containing 0.1 M HEPES-Na, pH 7.5, and 1.4 M trisodium citrate dihydrate.
Data Collection, Structure Determination, and RefinementThe initial native data set for Mtb apo-ADK was collected at 1.5-Å resolution at APS-23ID (Advanced Photon Source) in the C2 space group (Table 1 ). Molecular replacement of the apo-ADK data were attempted with a search model of 2-keto-3-deoxygluconate kinase from Thermus thermophilus (Protein Data Bank code 1v1s (25)) using various programs (PHASER, MOLREP, EPMR, and AMORE). However, no reasonable solution was obtained from the whole molecule or separate domains. Therefore, experimental phases from the SeMet incorporated apo-ADK crystal were obtained using the MAD phasing method (26) (supplementary materials Table 1 ). The SeMet ADK crystal diffracted up to 2.4-Å resolution at APS-23ID in the P4 1 22 space group. Seven selenium sites were found using SHELXD with three different wavelength MAD data. SOLVE/RESOLVE (27) were used to refine the sites, calculate initial protein phases, and build the model. A final model was obtained after several cycles of manual model building using XTALVIEW (28) . This 2.4-Å model was then used as a search model against 1.5-Å resolution data using PHASER (29) in the C2 space group. The solution for two molecules of the C2 asymmetric unit was refined using REFMAC (30) and built using XTALVIEW. Data sets of binary complexes of ADK⅐Ado, ADK⅐F-Ado, and ADK⅐AMP-PCP were collected on our home source using an R-axis IV imaging plate system and rotating anode x-ray generator equipped with osmic mirrors. All the ADK⅐ligand complex structures were solved with the molecular replacement method by PHASER using Molecule A of the 1.5-Å apo-ADK structure as a search model. Bias-minimized electron density maps were obtained using the Shake&wARP protocol (31) . Clear electron density for Ado, 2-fluoroadenosine (F-Ado), and AMP-PCP (Fig. 1A and supplementary materials Fig. S1 ) was visible in the SNW map prior to any model building. Several cycles of manual model building and maximum likelihood refinement in REFMAC5 yielded the final model.
All the crystals were mounted in cryo-loops and were flashcooled in a liquid N 2 stream after brief soaks in N-paratone oil. The binary complex data sets were processed using CRYSTAL CLEAR (Molecular Structure Corporation, Inc., Woodlands, TX), and the apo-ADK data sets were processed using HKL2000 (32) ( Table 1) . Solvent molecules were identified using Xfit (28) .
The final models of the apo-ADK, ADK⅐adenosine, ADK⅐2-fluoroadenosine, and ADK⅐AMP-PCP structures have excellent stereochemistry, as determined by Ramachandaran plot (calculated by PROCHECK (33, 34) ), and the crystal data and final refinement statistics are given in Table 1 . The figures were prepared using Spock (35), Raster3D (36) , and Chimera (37) . The atomic coordinates of apo and binary complexes have been deposited in the Protein Data Bank with the codes 2PKF (apo), 2PKM (Ado), 2PKK (F-Ado), and 2PKN (AMP-PCP).
RESULTS AND DISCUSSION
The x-ray crystal structure of Mtb apo-ADK with one molecule in the asymmetric unit was solved using the MAD method with crystals of selenomethionylated protein formed in the space group P4 1 22 at 2.4-Å resolution. Apo-ADK also crystallized in the C2 space group with two molecules (A and B) in the asymmetric unit, and these crystals diffracted to 1.5-Å resolution. The comparison of both subunits of C2 apo-ADK with the SeMet ADK reveals that the overall structure of these protomer was not severely affected by their crystal packing; the r.m.s. deviation between these protomer (after omitting their crystal contact region (␣2, ␣7-9)) is less than 0.2 Å. ADK co-crystals were produced after the incubation of protein with adenosine (Ado), AMP-PCP, or 2-fluoroadenosine (F-Ado) ( Table 1 ). The ADK⅐AMP-PCP crystal was in the C2 space group and diffracted to 1.9-Å resolution; ADK⅐Ado and ADK⅐F-Ado crystals are in the P3 1 2 1 space group and diffracted to 1.9-Å resolution. All of the ADK⅐ligand complex structures were solved with the molecular replacement method using the 1.5-Å resolution apo-ADK subunit as a search model.
Overall Structure-Like the E. coli RK and human ADK structures, each subunit of Mtb ADK contains a small lid domain (residues 9 to 48 and 99 to 120) and a large ␣/␤ domain (residues 1 to 8, 49 to 98, and 121 to 323) (Fig. 1B) . The small lid domain is formed by 5 ␤ strands (␤2, ␤3, ␤4, ␤8, and ␤9) and a short helix, ␣1. The large domain is an ␣/␤ domain consisting of ␣(9 -14)/␤ (12-15) and ␣(3-8)/␤ (1, 5, 6, 7, 10, 11). The ␤1, ␤5, ␤6, ␤10, and ␤11 strands are all parallel, reside in approximately the same plane, and associate with ␣ (3-8). ␤ Strands 12-15 are also roughly planar and associate with ␣ (9 -14). The large 
where I hi is the ith observation of the reflection h, whereas ͗I h ͘ is the means intensity of reflection h.
R free was calculated with a fraction (5%) of randomly selected reflections excluded from refinement.
domain makes no significant interactions with the small domain in the apo-structure.
In the crystal lattice of the apo-structure, each independent molecule of the asymmetric unit forms a tight, intact dimer with a twofold symmetry related subunit (Fig. 2) . The majority of the dimer interface results from the interaction of the ␤ strands of the small lid domain that protrude from the large ␣/␤ domain of each subunit. Four of the ␤ strands (␤2, ␤4, ␤8, and ␤9) of the lid domain are more or less planar, whereas ␤3 points away from this plane forming no intrasubunit interactions. However, the ␤3Ј strand of the symmetry related subunit is anti-parallel with ␤9, completing a 5 ␤-stranded extended sheet (␤2, ␤4, ␤8, ␤9, and ␤3Ј). These ␤ strands pack close to each other, forming a flattened ␤ barrel at the center of the dimer. The dimer interface of the 5 ␤-stranded sheet of each subunit is formed primarily via hydrophobic interactions (see supplementary materials Table 2 of both subunits interact with each other through hydrogen bond interactions, forming a positive patch of electrostatic surface potential at the bottom of the ␤ barrel. The significance of this positive surface is not clear at this point; however, it is possible that this region might bind other molecules like inorganic phosphates. It has been previously shown that inorganic phosphates can act as activators of mammalian ADK (38) . In both subunits of the apo-enzyme dimer, the substrate binding pocket is completely open and is freely accessible to solvent; hence, we refer to the apo-ADK structure as an "open dimer" (Fig. 2A) .
The ADK⅐AMP-PCP Binary Complex Is Very Similar to the
Apo-ADK Structure-The structure of the ADK⅐AMP-PCP complex reveals that each subunit of the dimer binds to a single AMP-PCP molecule. The ADK⅐AMP-PCP dimer is very similar to that of apo-ADK (r.m.s. deviation of the C␣s of the dimers is 0.75 Å). This indicates that the binding of AMP-PCP has no significant effect on the relative orientation of the substrate binding pocket, lid domain, or dimer interface. AMP-PCP is located in a shallow cleft formed by the ends of ␤ strands ␤12, ␤13, ␤14, and ␤15, and ␣ helices ␣11 and ␣12 on the enzyme surface. The small loop between ␤13 and ␤14 is named "small ATP binding loop," and the loop between ␤15 and ␣11 is named "large ATP binding loop" (according to the E. coli RK nomenclature). The ␥-phosphate of the AMP-PCP is positioned at the end of this shallow binding pocket, ϳ5 Å away from the Ado binding pocket (Fig. 4A) , respectively. The Glu 246 side chain is disordered in the electron density map; however, the backbone of Glu 246 is positioned so that the side chain could interact with either N-1, N-6, or both of the base of AMP-PCP in one orientation. The ribose sugar is stacked with the side chain of Phe 259 4.4 Å away. The O-3Ј atom of the ribose sugar makes a direct hydrogen bond (2.8 Å) with the main chain oxygen of Gly 228 , whereas O-2Ј makes a water-mediated interaction with the side chain oxygen of Ser 281 (Fig. 4A) . The phosphate groups of AMP-PCP form hydrogen bonds either directly with the protein or through intervening solvent molecules. Residues that interact with the phosphate groups are Thr 223 (the (Fig. 2C) . In addition, the intact ADK.Ado dimer is quite different compared with that of the open form of apo-ADK, as shown in Fig. 2 (r.m. s. deviation of the C␣s of the apo dimer and ADK.Ado dimer is 11.0 Å). Unlike the tight ␤ barrel formation of the open dimer, the 5 ␤-stranded lids of the dimer move apart toward the large ␣/␤ domain to form what we refer to as a "closed dimer" (Fig. 2B) Table 2 ). These dramatic domain movements, rearrangement of residues, and formation of the closed dimer facilitate the direct interactions of the lid region with the substrate as described below (Fig. 2C) . Table 2 ) (Fig. 2C) . Thus, it is evident that the loop closure is a critical requirement for the binding of the Ado substrate and the subsequent catalysis.
Binding Interactions of Ado-In
Comparison with E. coli RK-The overall structure of Mtb ADK is similar to E. coli RK (Fig. 3A) . The dimerization through the formation of the 10 ␤-stranded ␤ barrel arrangement is comparable with the 8 ␤-stranded ␤ clasp of the E. coli RK structure. Whereas notable lid movements were also observed in E. coli RK, compared with that of its native open form they were smaller in magnitude (39) . As described in the Mtb apo-ADK structure discussion, the lid domain moves between 2.2 and 17.0 Å upon the binding of Ado. In contrast, the lid domain of E. coli RK undergoes a movement that is only about 1.0 Å after binding ribose. Fig. 3A shows the superimposition of the subunits of Mtb apo-ADK, apo-RK, and RK⅐ribose/AMP-PCP. It is evident from this superposition that the lid domain (particularly ␤8 and ␤9) is more orthogonal to the ␣/␤ domain in the Mtb apo-ADK structure compared with that of E. coli apo-RK. The open and closed dimerization is very distinct in Mtb ADK. Superimposition of the Mtb ADK dimer with the apo or ternary complex dimer of E. coli RK yielded r.m.s. deviations of more than 7.0 Å, confirming that the relative arrangement of the lid and ␣/␤ domain in Mtb ADK is quite different compared with that of E. coli RK. The axis defined by the central ␤ barrel of the apo-Mtb ADK is at a right angle to the domain and is located distinctly away from the substrate binding pockets, whereas in the E. coli apo-RK structure the lid domains were curved toward the ␣/␤ domain. The E. coli apo-RK buried 7.4% of the surface area per subunit, and the substrate-bound RK complex structure buried 8.4%. Whereas Mtb apo-ADK buried 11.9% surface area per subunit, and the ADK⅐Ado binary complex buried 14.9%. As a result, the substrate binding pocket of Mtb apo-ADK is completely accessible, whereas it has limited accessibility in E. coli apo-RK.
Comparison of the Mtb ADK⅐Ado binary complex subunit with the ternary complex structure of E. coli RK (PDB code 1RKD) gives r.m.s. deviation of 1.3 Å for the C␣ carbons (198 C␣s were compared). Similar comparison with the apo-RK structure gives a r.m.s. deviation of 1.5 Å. The most significant structural differences are found at two insertion regions and one deletion region of Mtb ADK compared with E. coli RK. The first insertion of 17 residues (residues 20 -36) is observed in the ␤3, ␣1 of the lid domain. Another difference between E. coli RK and Mtb ADK is evident at the C-terminal insertion in Mtb ADK (309 -323 at ␣14). This C-terminal helix ␣14 makes a direct interaction with the ATP binding helix ␣12 and a large ATP binding loop (Arg 306 forms a salt bridge with Glu 289 , OH of Tyr 311 forms a hydrogen bond with the backbone oxygen of Gly 242 , and Tyr 311 makes hydrophobic interaction with Val 241 ) and accounts for the 12-residue deletion near the small ATP binding loop. The third difference is a 12-amino acid deletion of Mtb ADK (residues 196 -208), compared with that of E. coli RK. In E. coli RK, Asp 202 of this insertion makes a salt bridge (2.7 and 3.2 Å) with the Arg 227 of the small ATP binding loop and may allosterically affect the ATP binding. Moreover, the backbone torsion of residue 226 of E. coli RK shows a maximum movement upon the binding of ATP (39) .
A comparison of the apo and the ternary complex structure of E. coli RK revealed significant changes in the large and small ATP binding loops (11, 39) upon substrate binding. The large ATP binding loop of the E. coli RK structure has been shown to interact with the lid region upon the binding of the substrates and displayed significant conformational changes. It has been proposed that in E. coli RK, ribose is expected to bind the open form first and stabilize the closed conformation, whereas the lid region allosterically prepares the ATP binding pocket for the reaction (39) . Mtb ADK does not seem to follow this induced fit mechanism proposed for E. coli RK, as there are no significant conformational changes evident in either of the ATP binding loops between the apo and binary Mtb ADK structures. Interestingly, AMP-PCP binds to ADK in the open form, proving that the closed form is not a prerequisite for ATP binding. Moreover, the ADK⅐Ado binary complex forms a closed dimer, thus limiting the accessibility of the ATP binding pocket.
Comparison with Human ADK-Although the sequences of the Mtb and human ADK are less than 20% identical, their overall structures are similar (12) . Fig. 3B shows the comparison of the human ADK⅐(Ado) 2 complex with the Mtb apo-ADK. The large ␣/␤ domains of both structures were similar to each other in the overlaid regions. The human ADK lid domain is composed of 4 ␤ strands and 2 ␣ helices. Interestingly, the ␣2 helix of human ADK runs across its ␤ sheet of the lid domain and rules out the possibility of dimer formation (Fig. 3B) . Mtb ADK and E. coli RK are dimers with only one helix in the lid domain.
ADK Active Site-The structure of the active ADK binary complexes indicates that the enzyme has a pre-formed anion hole. It has been shown that the formation of an anion hole immediately adjacent to the ␥-phosphate of the ATP is one of the structural requirements for the reaction mechanism (40, 41) . Previous studies have also proposed that ATP binding might play an important role in inducing the local conformational changes near the ␥-phosphate to favor the anion hole formation (41) . However, the conformation of the anion hole is identical in apo and ADK⅐Ado (see below) or ADK⅐AMP-PCP binary complex structures. Neither the AMP-PCP nor Ado binding seem to play any role in the formation of the anion hole.
Attempts to crystallize ADK with Ado and AMP-PCP or to soak AMP-PCP into crystals (in presence of MgCl 2 ), and vice versa, were unsuccessful. Therefore, we have constructed a model of the ternary complex simply by superimposing the ADK⅐Ado and ADK⅐AMP-PCP binary complex structures. Fig. 4A shows the superposition of the binding pockets of ADK⅐AMP-PCP (non-hydrolyzable ATP analog) and ADK⅐Ado. Based on the constructed ternary complex model, the distance between the ␥-phosphorus of AMP-PCP and the O-5Ј atom of Ado is 5.6 Å. Comparable atoms in ternary complexes of phosphofructokinase are separated by 4.3-5.9 Å (42) and 5.6 Å in the E. coli RK (11) . These distances are little less than ideal for an optimal phosphoryl transfer reaction. It has been suggested that these kinases will undergo minor structural rearrangement to force the ATP toward the substrate binding pocket (11, 42) . Interestingly, two water molecules are conserved near the ␥-phosphate in both binary complex structures of Mtb ADK (labeled W1 and W2 in Fig.  4A ). The active site conserved water molecule W-1 is well ordered in the anion hole, created by the combination of the main chain amide nitrogen of Val 255 and Gly 256 . W-2 makes a hydrogen bond with the oxygen atom of both ␤-and ␥-phosphates of AMP-PCP. Interestingly, W-2 is observed close to the proposed conserved magnesium binding motif, N 195 XXE 198 , for ADKs (43) . In the Mtb ADK⅐AMP-PCP binary complex structure, the OE-2 atom of Glu 198 is at 3.6 Å from the W-2 atom and ND-2 of Asn 195 is at 4.4 Å. Although there is no strong electron density corresponding to magnesium ion binding in the Mtb ADK⅐AMP-PCP binary complex structure, it is possible that Mg 2ϩ can either replace W-2 or bind between W-2 and Asn 195 and Glu 198 in the ternary complex structure. In all known ADKs, an aspartic acid residue acts as a base to deprotonate the 5Ј-hydroxyl group of adenosine to activate it for nucleophilic attack on the ␥-phosphate of ATP (40) . Mtb ADK uses Asp 257 as the base to abstract a proton from the 5Ј-hydroxyl group of ribose. The negatively charged O-5Ј atom (at 2.6 Å from the OD-2 Asp 257 ) could then make a watermediated (W-1) nucleophilic attack on the ␥-phosphate of ATP. The resulting charge difference on the water can be nullified by an anion hole created by the main chain nitrogens of residues 255-257. This state may be further stabilized by the side chains of Gln 172 and Asn 252 . Thus, as a consequence of water-mediated phosphorylation, the products AMP and ADP would be formed via an S n 2 reaction. The second water molecule, W-2, might also play a role in stabilizing the products. In contrast, based on proposed reaction mechanisms of all other ADK structures, the ␥-phosphorus should make direct contact with both the anion hole and the O-5Ј of the Ado. However, one cannot completely rule out the possibility of direct phosphorylation for Mtb ADK in which the localized conformational change of the binding pocket residues will push the ATP closer to the Ado so that the ␥-phosphate will replace W-1. For example, a blocked anion hole has been observed in the crystal structure of human ADK. It has been argued that the human enzyme needs to undergo local conformational changes to form an active anion hole and, in turn, an active monomer (12) . In human and its close homolog apo Toxoplasma gondii ADK structure, the center of the oxyanion hole is blocked by the carbonyl oxygen of their Ϫ3rd residue (13) (comparable with the Ϫ3rd residue from Asp 257 of Mtb ADK). Comparison of active and inactive anion holes of ADK is illustrated in supplementary materials Fig. S2 . In the ternary complex structure of T. gondii, the Ϫ3rd residue moves away to form an unblocked anion hole. In contrast, the anion hole is well formed in Mtb ADK and is not blocked in either the apo-or substrate-bound structures and, therefore, does not need to undergo large conformational changes to perform the phosphorylation of Ado.
ADK⅐F-Ado Binary Complex Structure-Previous studies have shown that nucleoside analogs, like F-Ado and 2-methyladenosine, are preferred substrates to Mtb ADK compared with human ADK (15, 19) . Recently, a series of halogenated 3-deaza-Ado analogs were shown to have ADK-dependent antitubercular activity with a minimum inhibitory concentration of 1.6 mg/liter (23) . F-Ado readily yielded diffraction quality crystals in similar crystallization conditions as Ado-bound co-crystals. However, methyladenosine co-crystallization was unsuccessful. The overall structure of the ADK⅐F-Ado binary complex is very similar to that of the ADK⅐Ado complex structure (r.m.s. deviation for C␣s is 0.20 Å). The superposition of Ado and F-Ado binding pockets in Mtb ADK were almost identical, suggesting that the binding of F-Ado does not alter the binding pocket relative to Ado (Fig.  4B) . The significance of F-Ado lies in its complementarity to the ADK binding pocket. The 2-fluoro substitution forms seven additional non-bonding interactions with the binding pocket residues without altering the conformation of active site residues ( Fig. 4B and Table 2 ). F-Ado also positions its O-5Ј atom in an identical position compared with that of the Ado complex structure for a phosphorylation reaction to produce the 2-fluoro-substituted product (2-fluoroadenosine monophosphate). Earlier studies have also shown that 2-methyladenosine (a close analog of F-Ado) is monophosphorylated intracellularly by ADK in Mtb (15) . The Ado binding pocket of Mtb ADK is quiet different when compared with that of human ADK, as shown in Fig. 5 . In a hypothetical model of F-Ado in the human structure, the 2-fluoro substitution can only make two additional interactions with the protomer (Table 2 ). This noticeable difference in the binding pocket of F-Ado between human and Mtb ADK was also reflected in the biochemical structure-activity relationship studies (19, 23) . Thus, F-Ado can bind more specifically and strongly to Mtb ADK than it can to human ADK.
